PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death.
about
RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway.Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration.miR-137 effects on gastric carcinogenesis are mediated by targeting Cox-2-activated PI3K/AKT signaling pathway.MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma.Knockdown of AXL receptor tyrosine kinase in osteosarcoma cells leads to decreased proliferation and increased apoptosis.Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic SignificanceRLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis.A Novel Role of IGF1 in Apo2L/TRAIL-Mediated Apoptosis of Ewing Tumor Cells.Prognostic value and functional role of ROCK2 in pediatric Ewing sarcoma.Stromal resistance of fibroblasts against oxidative damage: involvement of tumor cell-secreted platelet-derived growth factor (PDGF) and phosphoinositide 3-kinase (PI3K) activation.Methylselenol generated from selenomethionine by methioninase downregulates integrin expression and induces caspase-mediated apoptosis of B16F10 melanoma cells.
P2860
Q33662727-3C74199C-00C3-4F21-943C-C14DD9779DEFQ34059738-BD54F8DF-C917-43BF-99D3-1E0DD81AD2E7Q38103561-8EFB063C-E0C1-40CD-93F3-7A5BCE77B816Q38971368-6E631872-E00E-4B08-A728-209330E85E5DQ39024985-F289BB64-5A4E-4AE1-8868-2B97748B1AB9Q39101609-B8E83105-9361-42EF-A7E4-9709D9579B46Q39175955-F58AB780-FCC0-45D6-AB5C-A33219CE6492Q41364679-6E3A0ED8-7377-4CB1-8E92-53520E7918BDQ41682526-C2D68A13-03CA-42E9-9A94-BD6D62ED4E43Q42106350-30F6D36F-77BB-4AD0-9D6C-058B0B3442F8Q42429522-32339FE4-ED7A-4BAD-82FE-C9BC983425FAQ49772405-858AF417-B1D0-4817-9629-8235C057DE0BQ50138285-F26A17A1-7785-402C-B03C-85734175053FQ53566584-2469947A-F133-440D-BA5A-530F5911B138
P2860
PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@en
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@nl
type
label
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@en
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@nl
prefLabel
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@en
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@nl
P2093
P2860
P356
P1476
PI3K/AKT is involved in mediat ...... h factor 2-induced cell death.
@en
P2093
F van Valen
M Hotfilder
P Sondermann
P2860
P2888
P304
P356
10.1038/SJ.BJC.6602384
P407
P577
2005-02-01T00:00:00Z
P5875
P6179
1013380636